More about

Eosinophilic Esophagitis

News
August 01, 2024
3 min read
Save

Top news of July: Anaphylaxis guidelines, epinephrine, FDA applications, more

Top news of July: Anaphylaxis guidelines, epinephrine, FDA applications, more

Healio has compiled July’s most-read news in asthma and allergy.

News
July 25, 2024
6 min read
Save

Eosinophilic esophagitis assessment correlates with clinical, molecular features

Eosinophilic esophagitis assessment correlates with clinical, molecular features

Researchers found associations between Index of Severity for Eosinophilic Esophagitis scores and select clinical features across categories of disease severity, according to a study published in The Journal of Allergy and Clinical Immunology.

News
July 19, 2024
2 min read
Save

Dupixent induces histologic remission in up to 68% of children with PPI-refractory EoE

Dupixent induces histologic remission in up to 68% of children with PPI-refractory EoE

Treatment with Dupixent led to histologic remission at week 16 among a greater percentage of pediatric patients with eosinophilic esophagitis refractory to proton-pump inhibitor therapy compared with placebo, according to study results.

News
July 03, 2024
4 min read
Save

Children achieve remission in eosinophilic esophagitis with dupilumab

Children achieve remission in eosinophilic esophagitis with dupilumab

There were significant differences in percentages of children with eosinophilic esophagitis who experienced histologic remission with dupilumab compared with placebo, according to a study published in The New England Journal of Medicine.

News
May 31, 2024
2 min read
Save

Weight gain during diet therapy linked to ‘worse EoE outcomes’ no matter baseline weight

Weight gain during diet therapy linked to ‘worse EoE outcomes’ no matter baseline weight

WASHINGTON — Among adults with eosinophilic esophagitis, weight gain while undergoing dietary therapy was associated with poor treatment response, regardless of baseline weight status, according to data presented at Digestive Disease Week.

News
May 28, 2024
2 min read
Save

Endoscopic, histologic improvements in EoE sustained at 52 weeks with etrasimod

Endoscopic, histologic improvements in EoE sustained at 52 weeks with etrasimod

WASHINGTON — Once-daily etrasimod 1 mg and 2 mg was well-tolerated and sustained improvements in histological and endoscopic features of eosinophilic esophagitis, as well as patient symptoms, through 52 weeks of treatment, according to data.

News
May 24, 2024
3 min read
Save

Researcher seeks to better understand how eosinophilic GI disorders impact women’s health

Researcher seeks to better understand how eosinophilic GI disorders impact women’s health

Improving understanding of eosinophilic gastrointestinal disorders and their impact on women’s health and pregnancy has personal roots for Jenny Huang, MD, because a few years ago, she was diagnosed with eosinophilic gastritis.

News
April 10, 2024
2 min read
Save

Urban, rural environments impact eosinophilic esophagitis-related anxiety, depression

Urban, rural environments impact eosinophilic esophagitis-related anxiety, depression

WASHINGTON — Urban and rural environments differed in eosinophilic esophagitis time to diagnosis and disease-related anxiety and depression, according to a poster at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

News
April 09, 2024
2 min read
Save

Corticosteroids do not impact growth velocity in children with eosinophilic esophagitis

Corticosteroids do not impact growth velocity in children with eosinophilic esophagitis

WASHINGTON — Swallowed corticosteroid treatment did not impact growth velocity among children with eosinophilic esophagitis, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

News
February 16, 2024
2 min read
Save

Top in allergy/asthma: COVID-19 vaccine reactions; Racial disparities in food allergies

Top in allergy/asthma: COVID-19 vaccine reactions; Racial disparities in food allergies

Most people who reported a reaction to a COVID-19 vaccine said they were unlikely to receive another vaccine in the future, according to a survey from Massachusetts General Hospital.

View more